#BEGIN_DRUGCARD DB03230

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C13H20N5O7P

# Chemical_IUPAC_Name:
{[(2S,3R,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(propoxy)phosphinic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Adenosine-5'-Propylphosphate

# HET_ID:
PRX

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C13H20N5O7P/c1-2-3-23-26(21,22)24-4-7-9(19)10(20)13(25-7)18-6-17-8-11(14)15-5-16-12(8)18/h5-7,9-10,13,19-20H,2-4H2,1H3,(H,21,22)(H2,14,15,16)/t7-,9-,10+,13+/m0/s1

# InChI_Key:
InChIKey=XAMXMSZRQHPMRX-UFAOYGAJSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3230

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
389.301

# Molecular_Weight_Mono:
389.110034531

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1PG3

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2.4

# Predicted_LogS:
-2.1

# Predicted_Water_Solubility:
2.98e+00 g/l

# Primary_Accession_No:
DB03230

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936616

# PubChem_Substance_ID:
46507162

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02666

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CCCO[P@@](O)(=O)OC[C@@H]1O[C@H]([C@H](O)[C@H]1O)N1C=NC2=C1N=CN=C2N

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:03 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AE008900

# Drug_Target_1_GenBank_ID_Protein:
16422835

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
acs

# Drug_Target_1_Gene_Sequence:
>1959 bp
TTATGACGGCATCGCGATGGCCTGCTTCTCTTCGAGCAGTTTCTCCACCACGCCAGGATC
GGCGAGAGTCGAGGTATCGCCCAGATTGCTGGTATCGCCCGCCGCGATTTTGCGCAAAAT
GCGGCGCATAATTTTGCCGGAACGGGTTTTTGGCAGTGAGTCGGTCCAGTGCAGCACGTC
CGGCGTCGCCAGTGGGCCAATCTCTTTACGTACCCAGTTGCGCACCTCCGCGTACAGTTC
TGGCGACGGCTCCTCGCCGTGGTTGAGCGTCACATAAGCGTAAATCGCCTGGCCTTTGAT
AGCGTGTGGAATACCCACCACCGCCGCTTCGGCGATCTTCGGATGCGCCACCAGCGCTGA
CTCGATTTCCGCCGTACCCAGACGGTGGCCGGAGACGTTTAACACGTCGTCCACGCGACC
GGTGATCCAGTAATAGCCGTCCTCATCGCGACGCGCGCCGTCGCCGCTGAAATACATATT
CTTAAAGGTAGAGAAATAGGTCTGCTCAAAACGTTCATGATCGCCGAACAGAGTGCGCGC
CTGGCCCGGCCAGGAATCGGTGATGACCAGATTGCCTTCCGTCGCGCCTTCTTGCGGATG
GCCTTCGTTATCCACCAGCGCAGGCTGTACGCCAAAGAAAGGACGGGTGGCGGAACCGGC
TTTCAGTTCGATAGCGCCTGGTAGCGGCGTGATCATAAAACCGCCTGTTTCAGTCTGCCA
CCAGGTGTCGACGACCGGACATTTTTCCTTGCCGATCTTCTTCCAGTACCATTCCCACGC
TTCGGGATTGATCGGCTCGCCGACGGAACCCAGAATGCGCAGTGAAGAACGGTCGGTGCC
TTCAATGGCTTTATCGCCTTCCGCCATCAGCGCGCGGATGGCCGTCGGGGCGGTATAGAG
AATGTTGACCTGGTGTTTGTCGACCACCTGGCACATGCGAGCGGGCGTTGGCCAATTCGG
CACGCCTTCAAACATTAAGGTGGTCGCGCCGCAGGCCAGCGGGCCATACAACAGATAGCT
GTGCCCCGTCACCCAACCCACATCGGCGGTACACCAGTAAATATCGCCAGGGTGATAATC
AAAGACATACTTAAAGGTGGTCGCGGCGTAGACCAGATAGCCGCCGGTGGTGTGCAGCAC
GCCTTTCGGCTTGCCGGTGGAGCCGGAGGTATAAAGGATAAACAGCGGATCTTCGGCATT
CATCGCTTCAGGCTGGTGCTCAGGGCTGGCTTTTTCAATCAAATCGCGCCACCACAGGTC
GCGGCCTTCTTGCCAGTCAATGTCGCTGCCGGTGCGCTTCAGGACGATCACATGCTCAAC
GCTAGTGACATTCGGGTTTTTCAGCGCGTCATCGACATTCTTTTTCAGCGGGATACTGCG
TCCGGCACGTACACCTTCGTCAGCGGTGATCACCAGCCGCGAGCTGGAGTCGATAATGCG
TCCGGCGACGGCTTCCGGCGAGAAGCCCCCGAAGATCACCGAATGCACCGCACCGATGCG
GGCGCAGGCCAACATTGCCACCGCCGCTTCCGGCACCATCGGCATATAAATCGCTACCAC
ATCGCCTTTTTTAATGCCCAGATCCAGCAGCGTATTCGCGAAACGGCAGACATCGCGATG
CAGTTCGCGATAAGAGATATGTTTACTCTGCGACGTGTCATCGCCTTCCCAGATAATGGC
GGTGCGATCGCCATTTTCCTGCAAATGGCGGTCAAGACAGTTCGCCGCCAGATTCAGCGT
GCCGTCCTCGTACCATTTAATCGACACATTGCCTGGCGCAAAGGAGGTGTTTTTCACTTT
TTGGTACGGCGTGATCCAATCGAGAATTTTTCCCTGTTCGCCCCAAAACGTATCGGGGTC
GTTAATAGACTGTTTATATTTAGTCTCATACTGCTCTGGATTTATCAGGCAACGATCCGC
AATGTTGGCGGGAATGGCGTGTTTATGTGTTTGGCTCAT

# Drug_Target_1_General_Function:
Lipid transport and metabolism

# Drug_Target_1_General_References:
11677609	McClelland M, Sanderson KE, Spieth J, Clifton SW, Latreille P, Courtney L, Porwollik S, Ali J, Dante M, Du F, Hou S, Layman D, Leonard S, Nguyen C, Scott K, Holmes A, Grewal N, Mulvaney E, Ryan E, Sun H, Florea L, Miller W, Stoneking T, Nhan M, Waterston R, Wilson RK: Complete genome sequence of Salmonella enterica serovar Typhimurium LT2. Nature. 2001 Oct 25;413(6858):852-6.
12493915	Starai VJ, Celic I, Cole RN, Boeke JD, Escalante-Semerena JC: Sir2-dependent activation of acetyl-CoA synthetase by deacetylation of active lysine. Science. 2002 Dec 20;298(5602):2390-2.
12627952	Gulick AM, Starai VJ, Horswill AR, Homick KM, Escalante-Semerena JC: The 1.75 A crystal structure of acetyl-CoA synthetase bound to adenosine-5'-propylphosphate and coenzyme A. Biochemistry. 2003 Mar 18;42(10):2866-73.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3489

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
72153

# Drug_Target_1_Name:
Acetyl-coenzyme A synthetase

# Drug_Target_1_Number_of_Residues:
652

# Drug_Target_1_PDB_ID:
1PG4

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00501	AMP-binding

# Drug_Target_1_Protein_Sequence:
>Acetyl-coenzyme A synthetase
MSQTHKHAIPANIADRCLINPEQYETKYKQSINDPDTFWGEQGKILDWITPYQKVKNTSF
APGNVSIKWYEDGTLNLAANCLDRHLQENGDRTAIIWEGDDTSQSKHISYRELHRDVCRF
ANTLLDLGIKKGDVVAIYMPMVPEAAVAMLACARIGAVHSVIFGGFSPEAVAGRIIDSSS
RLVITADEGVRAGRSIPLKKNVDDALKNPNVTSVEHVIVLKRTGSDIDWQEGRDLWWRDL
IEKASPEHQPEAMNAEDPLFILYTSGSTGKPKGVLHTTGGYLVYAATTFKYVFDYHPGDI
YWCTADVGWVTGHSYLLYGPLACGATTLMFEGVPNWPTPARMCQVVDKHQVNILYTAPTA
IRALMAEGDKAIEGTDRSSLRILGSVGEPINPEAWEWYWKKIGKEKCPVVDTWWQTETGG
FMITPLPGAIELKAGSATRPFFGVQPALVDNEGHPQEGATEGNLVITDSWPGQARTLFGD
HERFEQTYFSTFKNMYFSGDGARRDEDGYYWITGRVDDVLNVSGHRLGTAEIESALVAHP
KIAEAAVVGIPHAIKGQAIYAYVTLNHGEEPSPELYAEVRNWVRKEIGPLATPDVLHWTD
SLPKTRSGKIMRRILRKIAAGDTSNLGDTSTLADPGVVEKLLEEKQAIAMPS

# Drug_Target_1_Reaction:
ATP + acetate + CoA = AMP + diphosphate + acetyl-CoA

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Enables the cell to use acetate during aerobic growth to generate energy via the TCA cycle, and biosynthetic compounds via the glyoxylate shunt. Acetylates cheY, the response regulator involved in flagellar movement and chemotaxis

# Drug_Target_1_SwissProt_ID:
Q8ZKF6

# Drug_Target_1_SwissProt_Name:
ACSA_SALTY

# Drug_Target_1_Synonyms:
Acetate--CoA ligase
Acyl- activating enzyme
EC 6.2.1.1

# Drug_Target_1_Theoretical_pI:
5.71

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB03230
